Breaking News

You are here » Indian-Commodity  :  Corporate  :  S&P affirms ratings assigned to bank facilities of ICICI Bank


S&P affirms ratings assigned to bank facilities of ICICI Bank

Global rating agency, S&P has affirmed its 'BBB-' long-term and 'A-3' short-term foreign currency issuer credit ratings on ICICI Bank. The outlook on the long-term rating is stable. The agency has also affirmed issue ratings on the bank's outstanding senior unsecured notes and Basel II compliant tier 2 hybrid notes.

The agency has affirmed the ratings because it expects the bank to maintain its strong business position supported by its good business diversity, and its satisfactory capitalization and funding, despite weakening asset quality.

The agency expects the bank's credit costs to remain high because of continued pressure on asset quality, given the tough operating conditions for capital intensive corporate sectors in India.

Related News

View all news

IndiGo launches new offer for domestic, international flights: Report

InterGlobe Aviation (IndiGo) has reportedly launched new offer at Rs 899 for domestic flights and Rs 3,199 for international flights in its new sale. The 'Fare-tastic Winters!' offer is starting from November......

HDFC Bank to hike stake in CCIL

HDFC Bank will acquire 4% equity stake in Clearing Corporation of India (CCIL). The Bank currently holds 5% of the total equity capital of CCIL. Hence, it is proposed to increase the stake in CCIL from......

Indiabulls Housing Finance raises Rs 23,615 crore in last 2 months

Indiabulls Housing Finance has raised Rs 23,615 crore in the last 2 months from 32 financial institutions in various debt instruments, securitization and sanctions. Of the total of Rs 23,615 crore raised,......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......